These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22513945)

  • 1. Catheter ablation for paroxysmal and persistent atrial fibrillation.
    Chen HS; Wen JM; Wu SN; Liu JP
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007101. PubMed ID: 22513945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
    Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials.
    Wynn GJ; Das M; Bonnett LJ; Panikker S; Wong T; Gupta D
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):841-52. PubMed ID: 25132078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.
    Chen C; Zhou X; Zhu M; Chen S; Chen J; Cai H; Dai J; Xu X; Mao W
    J Interv Card Electrophysiol; 2018 Jun; 52(1):9-18. PubMed ID: 29549512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of medical management versus catheter ablation for atrial fibrillation.
    Mao YJ; Wang H; Chen JX; Huang PF
    Rev Cardiovasc Med; 2020 Sep; 21(3):419-432. PubMed ID: 33070546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis of Randomized Controlled Trials of Atrial Fibrillation Ablation With Pulmonary Vein Isolation Versus Without.
    Sau A; Howard JP; Al-Aidarous S; Ferreira-Martins J; Al-Khayatt B; Lim PB; Kanagaratnam P; Whinnett ZI; Peters NS; Sikkel MB; Francis DP; Sohaib SMA
    JACC Clin Electrophysiol; 2019 Aug; 5(8):968-976. PubMed ID: 31439299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials.
    Kampaktsis PN; Oikonomou EK; Y Choi D; Cheung JW
    J Interv Card Electrophysiol; 2017 Dec; 50(3):253-260. PubMed ID: 28887742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vein isolation with adjunctive left atrial ganglionic plexus ablation for treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Rackley J; Nudy M; Gonzalez MD; Naccarelli G; Maheshwari A
    J Interv Card Electrophysiol; 2023 Mar; 66(2):333-342. PubMed ID: 35419670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.
    Mujović N; Marinković M; Lenarczyk R; Tilz R; Potpara TS
    Adv Ther; 2017 Aug; 34(8):1897-1917. PubMed ID: 28733782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.
    Piccini JP; Lopes RD; Kong MH; Hasselblad V; Jackson K; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):626-33. PubMed ID: 20009077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.
    Liang JJ; Elafros MA; Muser D; Pathak RK; Santangeli P; Zado ES; Frankel DS; Supple GE; Schaller RD; Deo R; Garcia FC; Lin D; Hutchinson MD; Riley MP; Callans DJ; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.